Bortezomib for treatment of therapyrefractory antinmda. Antinmethyldaspartate nmda receptor encephalitis is a severe form of encephalitis associated with antibodies against nr1 and nr2 subunits of the nmda receptor and occurs primarily in women. It typically presents, like other forms of limbic encephalitis, with several days of progressively severe amnesia and behavioral disturbances. Anti nmda receptor antinmdar encephalitis was first described in 20071 and is now recognized as one of the most common forms of encephalitis. Antinmda receptor encephalitis practical neurology. Pitfalls in clinical diagnosis of antinmda receptor.
Therapeutic plasma exchange for the treatment of antinmda. Successful treatment of antinmda receptor encephalitis with early. He was suspected based on goiter, markedly elevated antithyroglobulin and antithyroid peroxidase antibody. A multidisciplinary approach to the treatment of antinmdareceptor antibody encephalitis.
Antinmda receptor antinmdar encephalitis was first described in 20071 and is now recognized as one of the most common forms of encephalitis. A positive serum or csf sample screening for antibodies to the nmdar subunit remains the gold. The term antinmda receptor nmdar encephalitis refers to an autoimmune disorder associated with igg antibodies against the nr1 subunit of the nmdar. Antinmethyldaspartate receptor nmdar encephalitis is a relatively recent autoimmune entity, as it was first described in 2007. As a potentially treatable differential for symptoms and signs seen in neurology and psychiatric clinics, clinicians practising across the lifespan should be aware of this form of encephalitis.
Case reporta 70yearold woman presented with acutely developed confusion, disorientations and psychosis. The identification of antinmda receptor nmdar encephalitis about 12 years ago made it possible to recognise that some patients with rapidly progressive psychiatric symptoms or cognitive impairment, seizures, abnormal movements, or coma of unknown cause, had an autoimmune disease. Successful treatment of antinmda receptor encephalitis. The clinical symptoms of this disorder correlate well with antibody titre. Diagnosis can be confirmed by detecting the nmda receptor antibody in.
The antinmdar antibody ab, was first identified in 2007 by dr. Nmdar antibody encephalitis the encephalitis society. A patient with encephalitis associated with nmda receptor. Pdf antinmdar nmethyldaspartate receptor encephalitis is a novel autoimmune and paraneoplastic disease often presenting as acute psychosis. Medical information about disease course, aeds and. Clinical features of seronegative, but csf antibody. Antinmdar antibodies in cerebrospinal fluid csf and serum are characteristic features of the disease, thereby. Cases with suspected but unconfirmed antinmda receptor encephalitis, or those receiving ect for other indications were excluded.
Conclusion anti nmda receptor encephalitis is a form of autoimmune encephalitis and is often misdiagnosed. Evaluation of seizure treatment in antilgi1, antinmdar. During the 8 months of followup period, three patients improved to. The term anti nmda receptor nmdar encephalitis refers to an autoimmune disorder associated with igg antibodies against the nr1 subunit of the nmdar. Antinmda receptor encephalitis journal of the intensive care.
According to the same study, 80% of patients with antinmdareceptor encephalitis eventually have partial or complete recovery. All patients with antinmdar encephalitis have nr1 antibodies in the. Pdf anti nmda receptor antibody encephalitis in pakistan. The gold standard for diagnosis is csf antibody detection, but a unique eeg finding of extreme delta brush has been associated with antinmda receptor encephalitis in adult patients. Originally described in 2005, antinmda receptor encephalitis is a syndrome characterized clinically by viral prodrome, followed by the onset of psychiatric symptoms, memory complaints, seizures, autonomic dysfunction, dyskinesia, and central hypoventillation. Antinmda receptor nmdar encephalitis is a severe but treatable autoimmune neurologic disease that often results in psychotic symptoms, seizures, dyskinesias, decreased level of consciousness, dysautonomia, or central hypoventilation. Five severely affected patients with antinmdar encephalitis with delayed treatment response or resistance to standard immunosuppressive and bcelldepleting drugs. The incidence of nmda antireceptor antibody encephalitis antinmdar is estimated at approximately 23 cases per million.
Antinmdareceptor encephalitis is an autoimmune disorder with a welldefined set of clinical features including psychiatric changes anxiety, agitation, bizarre behaviour, delusional or paranoid thoughts, epileptic seizures and cognitive disturbance followed by movement disorders including orofacial dyskinesias, alterations in the level of consciousness and dysautonomia. In this disease, autoantibodies serve as a diagnostic marker and alter nmdarrelated synaptic transmission. A multidisciplinary approach to the treatment of anti nmda receptor antibody encephalitis. Thus, the absence of serum nmdar antibodies in patients with suspected antinmdar encephalitis does not rule out this diagnosis, and these patients should be tested for csf antibodies. Antinmda receptor encephalitis accounted for 32 of those cases, and 65 percent of those patients were younger than 19. Antinmethyldaspartatereceptor nmdar encephalitis is an autoimmune disorder with a wide spectrum of neuropsychiatric symptoms with a progressive clinical course and the possibility of effective management, which was first described in 2005 by vitaliani et al. We thank susan byrne and colleagues for their comments and questions.
It is often accompanied with teratoma or other neoplasm, especially in female patients. Lateonset antinmda receptor encephalitis september 17, 20. Pdf a multidisciplinary approach to the treatment of antinmda. The term autoimmune encephalitis appears in the medical literature in the 1970s and 1980s, the first specific ae antibody was identified in 2005 when dr. The gold standard for diagnosing antinmdar encephalitis is the detection of igg antibodies against the glun1 subunit of nmda receptors in either the csf or plasma.
To report pitfalls in the clinical diagnosis of antinmethyldaspartate receptor nmdar encephalitis. Although the prevalence of antinmdar encephalitis is unknown, it is becoming increasingly clear that autoimmune disease targeting synaptic proteins within the central nervous system cns cannot be dismissed as rare. Anti nmethyldaspartate nmda receptor encephalitis is the most common form of autoimmune encephalitis, caused by the interaction between an antibody and its target, located on glutamate. Additionally, the study showed that antinmda receptor encephalitis may be more common than any single infectious cause of encephalitis. Treatment strategies for autoimmune encephalitis yong. Methods antilgi1, antinmdar, and antigaba b r encephalitis patients with newonset seizures were included. Antinmethyldaspartate receptor nmdar encephalitis is potentially lethal, but it is also a treatable autoimmune disorder characterized by prominent psychiatric and neurologic symptoms. Diagnosis and treatment of rapidly progressive dementias september 2012. Prevalence and treatment of antinmda receptor encephalitis. Antinmethyldaspartate receptor antinmdar encephalitis is a severe neuroautoimmune disease that can lead to permanent disability or death peery et al.
The symptoms and signs seen in patients with nmdarantibody encephalitis can be distinctive and prompt clinicians to request the nmda receptor antibody test to diagnose this condition. Antinmda receptor encephalitis is a type of brain inflammation due to antibodies. The backbone of antinmda receptor encephalitis treatment includes tumor removal and immunotherapy. Antinmda receptor encephalitis, which results from antibodies directed against nmda receptors, is a variety of paraneoplastic limbic encephalitis. Corticosteroids, intravenous immunoglobulin ivig, plasma exchange, azathioprine.
A positive serum or csf sample screening for antibodies to the nmdar subunit remains the gold standard in the. Antinmdar encephalitis brain inflammation symptoms. Anti nmethyldaspartate receptor nmda r encephalitis is thought to be one of the common paraneoplasticassociated encephalitides. The disease mainly affects young people, with around 40% of cases under 18 years of age. Our reported criteria1 for antibody positivity are. Pregnancy outcomes in antinmda receptor encephalitis. Antinmethyldaspartate nmda receptor encephalitis is the most common of the recently described immunemediated encephalitides that associate with and are likely caused by antibodies to neuronal cell surface receptors or ion channels see limbic encephalitis. It is characterized by an inflammation of the brain, which can result in neurological. Given that it is a condition with neuropsychiatric symptoms.
Background hashimotos encephalopathy he and anti nmethyldaspartate receptor nmdar encephalitis have clinical overlaps. These findings may contribute to the guidelines of disease treatment and. It is characterised by psychotic symptoms, motor changes such as catatonia, seizurelike activity and dyskinesias. Between february 2001 and february 2011, nine patients were. Clinical diagnosis and treatment of pediatric anti. Neurologyw c seizures as first symptom of antinmda receptor encephalitis are more common in men february 18, 2014. Autoimmune etiology is increasingly recognized as a major cause of le along with the finding of the high prevalence of antinmethyldaspartate receptor nmdar antibodyassociated encephalitis after the discovery of the antibody 2 and the continued identification of additional novel antibodies in le. Thyroid autoantibody positive antinmethyldaspartate. While antinmda is the most studied of the antibodies, the treatment for ae regardless of antibody, is generally similar. Background antinmda receptor nmdar encephalitis is a recently characterised autoimmune disorder mainly affecting young women. Autoimmune encephalitis symptoms, treatment, antinmda. Antinmethyldaspartate receptor antinmdar encephalitis, an autoimmune disease associated with ovarian teratoma, predominantly affects young females. The test for antinmda receptor encephalitis, although currently somewhat slow, is. We assessed the therapeutic potential of the plasmacelldepleting proteasome inhibitor bortezomib in severe and therapyrefractory cases of antinmda receptor antinmdar encephalitis.
Consecutive specimens n1671 for antinmdar igg antibodies were evaluated and. Bortezomib treatment for patients with antinmdar encephalitis. The symptoms and signs seen in patients with nmdar antibody encephalitis can be distinctive and prompt clinicians to request the nmda receptor antibody test to diagnose this condition. References antibody titres at diagnosis and during followup of antinmda receptor encephalitis. Joseph dalmua described the antinmdareceptor encephalitis type. Cognitive deficits following antinmda receptor encephalitis. Antinmdar nmethyldaspartate receptor encephalitis is a novel autoimmune and paraneoplastic disease often presenting as acute psychosis.
With this diagnosis, the patient underwent a number of tests to identify potential tumor associations. Antinmethyldaspartate nmda receptor encephalitis is the most common form of autoimmune encephalitis, caused by the interaction between an antibody and its target, located on glutamate. Antinmethyldaspartate nmda receptor encephalitis is a form of encephalitis occurring primarily in women and associated with antibodies against nr1 or nr2 subunits of the nmda receptor. In this case study, the authors describe paraneoplastic psychosis and catatonia in a patient with encephalitis associated with an immature teratoma of. Antinmda receptor encephalitis is a serious autoimmune disease.
785 281 317 1316 794 198 1263 1130 735 749 1422 401 1512 1076 1274 617 1164 730 627 286 198 448 636 694 221 507 1288 1346 611 282 1076 1514 229 541 913 873 1030 140 671 428 1352 395 578 106 471 285 924